Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis
Background: Huntington's disease (HD) causes dysphagia and dementia, both of which are risk factors for malnutrition. Gastrostomy is used to sustain enteral intake in neurodegenerative diseases and specifically improves outcomes in ALS, but its indications and outcomes in HD are understudied. O...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590112520300098 |
id |
doaj-a5e0771bd1cd4c189219655f070545a4 |
---|---|
record_format |
Article |
spelling |
doaj-a5e0771bd1cd4c189219655f070545a42020-12-23T05:04:10ZengElsevierClinical Parkinsonism & Related Disorders2590-11252020-01-013100041Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosisAli G. Hamedani0Meredith Pauly1Dylan P. Thibault2Pedro Gonzalez-Alegre3Allison W. Willis4Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, University of Pennsylvania, Philadelphia, PA, United States of America; Corresponding author at: 3400 Spruce St, 3 W. Gates Bldg., Philadelphia, PA 19104, United States of America.Penn Therapy and Fitness, Pennsylvania Hospital, Philadelphia, PA, United States of AmericaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, University of Pennsylvania, Philadelphia, PA, United States of AmericaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Raymond G. Perelman Center for Cellular & Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of AmericaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, University of Pennsylvania, Philadelphia, PA, United States of America; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States of America; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, United States of AmericaBackground: Huntington's disease (HD) causes dysphagia and dementia, both of which are risk factors for malnutrition. Gastrostomy is used to sustain enteral intake in neurodegenerative diseases and specifically improves outcomes in ALS, but its indications and outcomes in HD are understudied. Objective: To explore the indications and outcomes for gastrostomy for HD. Methods: We performed a retrospective cross-sectional analysis of all HD admissions in the National Inpatient Sample. Logistic regression models compared the patient- and hospital-level characteristics associated with gastrostomy placement in HD and the prevalence of associated diagnoses in HD vs. ALS gastrostomy patients. We also examined in-hospital mortality, length of stay (LOS), and discharge status. Results: Between 2000 and 2010, 5.12% (n = 1614) of HD admissions included gastrostomy tube placement. Gastrostomy patients were more likely to be Black (adjusted odds ratio [AOR] 1.55, 95% CI: 1.09–2.21) and have Medicare coverage (AOR 1.43, 95% CI: 1.0–2.05). The most common comorbidities were aspiration pneumonia (34.1%), dementia (31.3%), malnutrition (30.3%), and dysphagia (29.5%). Dementia and delirium were associated with discharge type but not LOS. Aspiration pneumonia, sepsis, and Elixhauser comorbidity index were associated with LOS but not discharge type. Compared to 7908 ALS gastrostomy patients, those with HD more frequently had aspiration pneumonia (34.1% vs. 20.5%, p < 0.0001), sepsis (28.1% vs. 13.7%, p < 0.0001), prolonged LOS (OR 1.14, 95% CI: 1.02–1.28), and skilled nursing facility discharge (p < 0.0001, Wald chi square test). Conclusions: Gastrostomy is frequently performed in HD patients with dementia and aspiration pneumonia who are at increased risk for negative hospitalization outcomes.http://www.sciencedirect.com/science/article/pii/S2590112520300098Huntington's diseaseHealth services researchOutcome researchGastrostomy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ali G. Hamedani Meredith Pauly Dylan P. Thibault Pedro Gonzalez-Alegre Allison W. Willis |
spellingShingle |
Ali G. Hamedani Meredith Pauly Dylan P. Thibault Pedro Gonzalez-Alegre Allison W. Willis Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis Clinical Parkinsonism & Related Disorders Huntington's disease Health services research Outcome research Gastrostomy |
author_facet |
Ali G. Hamedani Meredith Pauly Dylan P. Thibault Pedro Gonzalez-Alegre Allison W. Willis |
author_sort |
Ali G. Hamedani |
title |
Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
title_short |
Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
title_full |
Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
title_fullStr |
Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
title_full_unstemmed |
Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
title_sort |
inpatient gastrostomy in huntington's disease: nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis |
publisher |
Elsevier |
series |
Clinical Parkinsonism & Related Disorders |
issn |
2590-1125 |
publishDate |
2020-01-01 |
description |
Background: Huntington's disease (HD) causes dysphagia and dementia, both of which are risk factors for malnutrition. Gastrostomy is used to sustain enteral intake in neurodegenerative diseases and specifically improves outcomes in ALS, but its indications and outcomes in HD are understudied. Objective: To explore the indications and outcomes for gastrostomy for HD. Methods: We performed a retrospective cross-sectional analysis of all HD admissions in the National Inpatient Sample. Logistic regression models compared the patient- and hospital-level characteristics associated with gastrostomy placement in HD and the prevalence of associated diagnoses in HD vs. ALS gastrostomy patients. We also examined in-hospital mortality, length of stay (LOS), and discharge status. Results: Between 2000 and 2010, 5.12% (n = 1614) of HD admissions included gastrostomy tube placement. Gastrostomy patients were more likely to be Black (adjusted odds ratio [AOR] 1.55, 95% CI: 1.09–2.21) and have Medicare coverage (AOR 1.43, 95% CI: 1.0–2.05). The most common comorbidities were aspiration pneumonia (34.1%), dementia (31.3%), malnutrition (30.3%), and dysphagia (29.5%). Dementia and delirium were associated with discharge type but not LOS. Aspiration pneumonia, sepsis, and Elixhauser comorbidity index were associated with LOS but not discharge type. Compared to 7908 ALS gastrostomy patients, those with HD more frequently had aspiration pneumonia (34.1% vs. 20.5%, p < 0.0001), sepsis (28.1% vs. 13.7%, p < 0.0001), prolonged LOS (OR 1.14, 95% CI: 1.02–1.28), and skilled nursing facility discharge (p < 0.0001, Wald chi square test). Conclusions: Gastrostomy is frequently performed in HD patients with dementia and aspiration pneumonia who are at increased risk for negative hospitalization outcomes. |
topic |
Huntington's disease Health services research Outcome research Gastrostomy |
url |
http://www.sciencedirect.com/science/article/pii/S2590112520300098 |
work_keys_str_mv |
AT alighamedani inpatientgastrostomyinhuntingtonsdiseasenationwideanalysisofutilizationandoutcomescomparedtoamyotrophiclateralsclerosis AT meredithpauly inpatientgastrostomyinhuntingtonsdiseasenationwideanalysisofutilizationandoutcomescomparedtoamyotrophiclateralsclerosis AT dylanpthibault inpatientgastrostomyinhuntingtonsdiseasenationwideanalysisofutilizationandoutcomescomparedtoamyotrophiclateralsclerosis AT pedrogonzalezalegre inpatientgastrostomyinhuntingtonsdiseasenationwideanalysisofutilizationandoutcomescomparedtoamyotrophiclateralsclerosis AT allisonwwillis inpatientgastrostomyinhuntingtonsdiseasenationwideanalysisofutilizationandoutcomescomparedtoamyotrophiclateralsclerosis |
_version_ |
1724373186175303680 |